Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
July 2019 – July 2021 · 3 captures · latest observed messagingDeveloping differentiated therapies that can improve the health of patients with liver and gastrointestinal (GI) diseases
We are an experienced team with internal drug discovery and development expertise focused on building a pipeline of best-in-class oral drugs for liver and gastrointestinal diseases.
21 July 2019 · Focused on developing innovative drugs that materially benefit patients with liver and gastrointestinal diseasesarchived page
24 January 2021 · Developing differentiated therapies that can improve the health of patients with liver and gastrointestinal (GI) diseasesarchived page
6 July 2021 · Developing differentiated therapies that can improve the health of patients with liver and gastrointestinal (GI) diseasesarchived page
Cite this record
StartupHistory, “Metacrine” company record, https://startuphistory.org/c/metacrine.com